Second, ddPCR was used to identify potential mutations in BRCA2, EGFR, ERBB2, KDR and KRAS, in a cohort of 188 metastatic pancreatic cancer patients [50]. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.